Evofem Biosciences Inc.

May 29, 2018

Evofem Biosciences to Present at Jefferies Global Healthcare Conference on June 7, 2018

May 24, 2018

Evofem Biosciences Announces Closing of Public Offering of Common Stock and Warrants

May 22, 2018

Evofem Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

Apr 24, 2018

Evofem Biosciences Announces Proposed Public Offering of Common Stock

Feb 15, 2018

Evofem Biosciences Completes Enrollment of Phase 3 Contraceptive Trial of Amphora Ahead of Schedule

Jan 23, 2018

Evofem Biosciences Announces First Patient Enrolled in Phase 2b/3 STI Trial of Amphora® and Expects Phase 3 Contraceptive Clinical Trial Data First Quarter 2019

Jan 17, 2018

Evofem Announces Closing Of Merger With Neothetics

Jul 27, 2017

Evofem Biosciences Announces First Patient Enrolled in a Phase 3 Clinical Trial of AMPHORA® (L-lactic Acid, citric acid, and potassium bitartrate) for Prevention of Pregnancy